Inspire Medical Systems, Inc. (INSP) stock
INSPNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 2, 2026Score 19/3057% below fair value
$59.41+0.29 (+0.49%)
Close on Nov 17, 2026Market cap $1.72BP/E 12.9Yield –
Inspire Medical Systems cash
Cash and short-term investments held at the end of each period.
Inspire Medical Systems's cash was $320.68M at Jun 30, 2026. For fiscal 2025 it was $308.27M, down 30.8% from the year before. The highest annual figure on record is $460.38M in fiscal 2023.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $308.27M | -30.8% |
| FY2024 | Dec 31, 2024 | $445.55M | -3.2% |
| FY2023 | Dec 31, 2023 | $460.38M | +2.0% |
| FY2022 | Dec 31, 2022 | $451.41M | +110.5% |
| FY2021 | Dec 31, 2021 | $214.47M | -8.5% |
| FY2020 | Dec 31, 2020 | $234.36M | +56.8% |
| FY2019 | Dec 31, 2019 | $149.47M | -20.6% |
| FY2018 | Dec 31, 2018 | $188.21M | +1065.9% |
| FY2017 | Dec 31, 2017 | $16.14M | +141.5% |
| FY2016 | Dec 31, 2016 | $6.69M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $320.68M | +6.6% |
| Q1 FY2026 | Mar 31, 2026 | $283.83M | -23.1% |
| Q4 FY2025 | Dec 31, 2025 | $308.27M | -30.8% |
| Q3 FY2025 | Sep 30, 2025 | $322.59M | -21.5% |
| Q2 FY2025 | Jun 30, 2025 | $300.90M | -31.6% |
| Q1 FY2025 | Mar 31, 2025 | $369.19M | -16.4% |
| Q4 FY2024 | Dec 31, 2024 | $445.55M | -3.2% |
| Q3 FY2024 | Sep 30, 2024 | $410.99M | -11.5% |
| Q2 FY2024 | Jun 30, 2024 | $439.66M | -5.9% |
| Q1 FY2024 | Mar 31, 2024 | $441.36M | -2.4% |
| Q4 FY2023 | Dec 31, 2023 | $460.38M | +2.0% |
| Q3 FY2023 | Sep 30, 2023 | $464.21M | +8.6% |
| Q2 FY2023 | Jun 30, 2023 | $467.05M | +137.9% |
| Q1 FY2023 | Mar 31, 2023 | $452.06M | +122.4% |
| Q4 FY2022 | Dec 31, 2022 | $451.41M | +110.5% |
| Q3 FY2022 | Sep 30, 2022 | $427.55M | +103.4% |
| Q2 FY2022 | Jun 30, 2022 | $196.32M | -5.5% |
| Q1 FY2022 | Mar 31, 2022 | $203.29M | -10.1% |
| Q4 FY2021 | Dec 31, 2021 | $214.47M | -8.5% |
| Q3 FY2021 | Sep 30, 2021 | $210.20M | -10.4% |
| Q2 FY2021 | Jun 30, 2021 | $207.84M | -14.3% |
| Q1 FY2021 | Mar 31, 2021 | $226.14M | +66.6% |
| Q4 FY2020 | Dec 31, 2020 | $234.36M | +56.8% |
| Q3 FY2020 | Sep 30, 2020 | $234.64M | +54.8% |
| Q2 FY2020 | Jun 30, 2020 | $242.56M | +52.9% |
| Q1 FY2020 | Mar 31, 2020 | $135.73M | -23.3% |
| Q4 FY2019 | Dec 31, 2019 | $149.47M | -20.6% |
| Q3 FY2019 | Sep 30, 2019 | $151.60M | +25.9% |
| Q2 FY2019 | Jun 30, 2019 | $158.62M | +28.0% |
| Q1 FY2019 | Mar 31, 2019 | $177.01M | +888.7% |
| Q4 FY2018 | Dec 31, 2018 | $188.21M | +1065.9% |
| Q3 FY2018 | Sep 30, 2018 | $120.43M | +728.2% |
| Q2 FY2018 | Jun 30, 2018 | $123.96M | +450.8% |
| Q1 FY2018 | Mar 31, 2018 | $17.90M | -32.6% |
| Q4 FY2017 | Dec 31, 2017 | $16.14M | +141.5% |
| Q3 FY2017 | Sep 30, 2017 | $14.54M | – |
| Q2 FY2017 | Jun 30, 2017 | $22.51M | – |
| Q1 FY2017 | Mar 31, 2017 | $26.55M | – |
| Q4 FY2016 | Dec 31, 2016 | $6.69M | – |
See a number that looks wrong?